MedTrace Logo

Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness

NCT03755596 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2019-09-25

No results posted yet for this study

Summary

This is an open-label, case control study of 180 patients presenting motion sickness, who will perform a motion sickness assessment questionnaire before and after treatment with dry ginger (Z. officinale) extract.

Conditions

Interventions

DRUG

Z. officinale extract

Oral dose of 160mg dry ginger root (Z. officinale) extract in tablet form.

Sponsors & Collaborators

  • Melora do Brasil Produtos Dermatológicos S/A

    collaborator UNKNOWN

  • Fundação Educacional Serra dos Órgãos

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2019-04-30
Completion
2019-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03755596 on ClinicalTrials.gov